Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Johnstone

Showing results (381-390 of 483) with videos related to

Pageof 49
Sort By:
Psychiatry Research|September 25, 1999
Methodological issues in volumetric magnetic resonance imaging of the brain in the Edinburgh High Risk ProjectH C Whalley, J N Kestelman, J E Rimmington, et al.
Pharmacogenetics|April 13, 2004
Genetic variation in dopaminergic pathways and short-term effectiveness of the nicotine patchElaine C Johnstone, Patricia L Yudkin, Kate Hey, et al.
Psychiatry Research|May 31, 2001
Diffusion tensor imaging (DTI) and proton magnetic resonance spectroscopy (1H MRS) in schizophrenic subjects and normal controlsR M Steel, M E Bastin, S McConnell, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|March 11, 2005
A functional genetic variation of the serotonin (5-HT) transporter affects 5-HT1A receptor binding in humansSean P David, Naga Venkatesha Murthy, Eugenii A Rabiner, et al.
Journal of Surgical Oncology|February 16, 2018
The value of additional bevacizumab in patients with high-risk stroma-high colon cancer. A study within the QUASAR2 trial, an open-label randomized phase 3 trialAnouck Huijbers, Gabi W van Pelt, Rachel S Kerr, et al.
Biological Psychiatry|December 21, 2010
Longitudinal volume reductions in people at high genetic risk of schizophrenia as they develop psychosisAndrew M McIntosh, David C Owens, William J Moorhead, et al.
The British Journal of Psychiatry : the Journal of Mental Science|December 5, 2015
Negative symptoms and longitudinal grey matter tissue loss in adolescents at risk of psychosis: preliminary findings from a 6-year follow-up studyAndrew G McKechanie, Thomas W J Moorhead, Andrew C Stanfield, et al.
Journal of Drug Targeting|June 7, 2006
Reversible lipidization for the oral delivery of leu-enkephalinJeffrey Wang, Derk J Hogenkamp, Minhtam Tran, et al.
Neuroimage|April 8, 2006
Automated computation of the Gyrification Index in prefrontal lobes: methods and comparison with manual implementationT William J Moorhead, Jonathan M Harris, Andrew C Stanfield, et al.
Biological Psychiatry|January 22, 2013
Longitudinal gray matter change in young people who are at enhanced risk of schizophrenia due to intellectual impairmentT William J Moorhead, Andrew C Stanfield, Andrew G McKechanie, et al.
Pageof 49

Showing results (381-390 of 483) with videos related to

Sort By:
Pageof 49
Psychiatry Research|September 25, 1999
Methodological issues in volumetric magnetic resonance imaging of the brain in the Edinburgh High Risk ProjectH C Whalley, J N Kestelman, J E Rimmington, et al.
Pharmacogenetics|April 13, 2004
Genetic variation in dopaminergic pathways and short-term effectiveness of the nicotine patchElaine C Johnstone, Patricia L Yudkin, Kate Hey, et al.
Psychiatry Research|May 31, 2001
Diffusion tensor imaging (DTI) and proton magnetic resonance spectroscopy (1H MRS) in schizophrenic subjects and normal controlsR M Steel, M E Bastin, S McConnell, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|March 11, 2005
A functional genetic variation of the serotonin (5-HT) transporter affects 5-HT1A receptor binding in humansSean P David, Naga Venkatesha Murthy, Eugenii A Rabiner, et al.
Journal of Surgical Oncology|February 16, 2018
The value of additional bevacizumab in patients with high-risk stroma-high colon cancer. A study within the QUASAR2 trial, an open-label randomized phase 3 trialAnouck Huijbers, Gabi W van Pelt, Rachel S Kerr, et al.
Biological Psychiatry|December 21, 2010
Longitudinal volume reductions in people at high genetic risk of schizophrenia as they develop psychosisAndrew M McIntosh, David C Owens, William J Moorhead, et al.
The British Journal of Psychiatry : the Journal of Mental Science|December 5, 2015
Negative symptoms and longitudinal grey matter tissue loss in adolescents at risk of psychosis: preliminary findings from a 6-year follow-up studyAndrew G McKechanie, Thomas W J Moorhead, Andrew C Stanfield, et al.
Journal of Drug Targeting|June 7, 2006
Reversible lipidization for the oral delivery of leu-enkephalinJeffrey Wang, Derk J Hogenkamp, Minhtam Tran, et al.
Neuroimage|April 8, 2006
Automated computation of the Gyrification Index in prefrontal lobes: methods and comparison with manual implementationT William J Moorhead, Jonathan M Harris, Andrew C Stanfield, et al.
Biological Psychiatry|January 22, 2013
Longitudinal gray matter change in young people who are at enhanced risk of schizophrenia due to intellectual impairmentT William J Moorhead, Andrew C Stanfield, Andrew G McKechanie, et al.
Pageof 49